PTSD - Nursing Case Study
Pathophysiology
• Primary mechanism: Dysregulation of the Hypothalamic-Pituitary-Adrenal (HPA) axis leads to altered cortisol levels, impairing stress response and potentially increasing anxiety and fear-related memories.
• Secondary mechanism: Hyperactivity of the amygdala and decreased function of the prefrontal cortex result in heightened emotional responses and impaired regulation of fear, contributing to persistent traumatic memories and exaggerated threat perception.
• Key complication: Chronic stress and heightened arousal can lead to increased risk for cardiovascular diseases and metabolic disorders, impacting overall health and requiring comprehensive management.
Patient Profile
Demographics:
32-year-old female, military veteran
History:
• Key past medical history: PTSD diagnosed 3 years ago, hypertension, and insomnia
• Current medications: Sertraline 100 mg daily, Lisinopril 10 mg daily, Zolpidem 5 mg as needed for sleep
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing anxiety and frequent nightmares
• Key symptoms: Flashbacks, irritability, difficulty concentrating, hypervigilance, and fatigue
• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F
Section 1
Following the initial assessment, the healthcare team noted that the patient's blood pressure remained elevated at 150/95 mmHg and her heart rate was persistently tachycardic at 105 bpm. Despite adherence to her current medication regimen, including Sertraline and Lisinopril, her hypertension appeared resistant to treatment, prompting further investigation into potential secondary causes. Additionally, her frequent nightmares and flashbacks have contributed to significant sleep disturbances, exacerbating her fatigue and irritability.
A comprehensive diagnostic workup was initiated to explore underlying causes and assess the extent of her PTSD-related complications. Blood tests revealed elevated fasting glucose levels of 115 mg/dL, suggesting the onset of glucose intolerance, possibly linked to chronic stress and HPA axis dysregulation. A lipid panel showed mildly elevated cholesterol levels, raising concerns about the potential development of metabolic syndrome, a common comorbidity in patients with PTSD.
The healthcare team decided to adjust her treatment plan to address these findings. An increase in her Lisinopril dosage was considered to better manage her hypertension, and a low-dose beta-blocker was added to control her heart rate and reduce anxiety symptoms. Additionally, the patient was referred to a dietitian for nutritional counseling to help manage her glucose levels and overall cardiovascular risk. Cognitive-behavioral therapy was recommended to address her persistent PTSD symptoms, aiming to improve her coping mechanisms and reduce the frequency of nightmares. The team planned to closely monitor her response to these interventions and reassess her condition in the coming weeks.
Section 2
A few weeks after the adjustments to her treatment plan, the patient returned for follow-up with her healthcare team. Her blood pressure showed slight improvement, now measuring at 142/90 mmHg, and her heart rate had decreased to 98 bpm with the addition of the low-dose beta-blocker. However, she reported continued episodes of insomnia and an escalation of her anxiety symptoms, despite adhering to her medication regimen and attending cognitive-behavioral therapy sessions. Her sleep disturbances persisted, with nightmares occurring at least three times a week, leaving her feeling even more fatigued and irritable.
Further diagnostic evaluation was conducted to ascertain the reasons behind her persistent symptoms. Her fasting glucose levels had increased slightly to 118 mg/dL, indicating a progression in her glucose intolerance. Additionally, a follow-up lipid panel revealed that her LDL cholesterol had risen to 145 mg/dL, reinforcing the concern for metabolic syndrome development. The team considered the impact of chronic stress and sleep disturbances on her metabolic and cardiovascular health, recognizing the need for a multifaceted approach to her treatment.
In light of these findings, the healthcare team decided to intensify her treatment strategy. Her Sertraline dosage was increased to better address her PTSD symptoms and anxiety. A referral to a sleep specialist was made to evaluate her sleep patterns and consider additional interventions such as sleep hygiene education or possible pharmacologic therapies for insomnia. The patient was also encouraged to engage in regular physical activity as part of her lifestyle modifications to help mitigate her metabolic risk factors. The team planned to reassess her condition in another month, with close monitoring of her metabolic parameters and PTSD symptoms, aiming to optimize her overall health and quality of life.
Section 3
A month later, the patient returned for her scheduled follow-up appointment. During the initial assessment, it was noted that her blood pressure had improved slightly to 138/88 mmHg, and her heart rate was now a steady 92 bpm. Despite these positive changes, she reported persistent difficulties with sleep, indicating that the nightmares had decreased in frequency to twice a week, but she continued to feel exhausted during the day. Her insomnia had only marginally improved with the addition of a melatonin supplement as per the sleep specialist’s recommendations. Furthermore, she expressed frustration over her continued anxiety and mood swings, which seemed to intensify during periods of inadequate rest.
New diagnostic results revealed that her fasting glucose had increased further to 124 mg/dL, edging closer to the threshold of diabetes, and her LDL cholesterol remained elevated at 148 mg/dL. These findings suggested that her metabolic syndrome was progressing, likely exacerbated by ongoing stress and sleep disturbances. Additionally, her weight had increased by 3 pounds since the last visit, raising concerns about her adherence to lifestyle modifications and physical activity recommendations.
The healthcare team recognized the need for a more integrated approach to address these complications. A collaborative consultation with an endocrinologist was suggested to evaluate and manage her potential prediabetes and dyslipidemia. The team also considered tailoring her cognitive-behavioral therapy to include stress management techniques that specifically target her anxiety and metabolic concerns. The patient was encouraged to maintain a detailed sleep and activity journal to identify potential triggers and patterns that could be contributing to her symptoms. The plan was to closely monitor her metabolic parameters and mental health symptoms over the next few months, with adjustments to her treatment plan as necessary to prevent further escalation of her condition.
Section 4
Two months later, the patient returned for another follow-up appointment, during which the clinical team conducted a comprehensive assessment to evaluate her progress. Her blood pressure was recorded at 140/90 mmHg, indicating a slight regression, and her heart rate remained stable at 90 bpm. The patient reported that her sleep issues persisted, with nightmares occurring once weekly, yet she continued to experience significant daytime fatigue. Despite adhering to the melatonin supplement, her sleep quality had not notably improved. She mentioned feeling on edge and irritable, especially during stressful situations, which seemed to exacerbate her anxiety and mood swings.
New diagnostic results revealed a fasting glucose level of 129 mg/dL, confirming the progression toward prediabetes. Her LDL cholesterol increased to 155 mg/dL, and her triglycerides were elevated at 200 mg/dL. Her weight gain continued, with an additional 2 pounds since the last visit. These findings raised concerns about the effectiveness of her current management plan and prompted the healthcare team to intensify their interventions. The endocrinologist suggested initiating metformin to help manage her glucose levels and recommended a more aggressive approach to her diet and exercise regimen. Meanwhile, the mental health team proposed introducing mindfulness-based stress reduction techniques into her cognitive-behavioral therapy sessions to better address her anxiety and metabolic health.
These developments required the patient to be more actively involved in her care plan, emphasizing the importance of lifestyle modifications alongside pharmacological interventions. The healthcare team arranged for frequent follow-ups to monitor the impact of these new strategies on both her metabolic and mental health parameters. They also encouraged the patient to continue documenting her sleep patterns, dietary intake, and activity levels to identify any correlations with her symptoms, aiming to refine her treatment plan and prevent further deterioration of her condition. With these adjustments, the team hoped to stabilize her health status and improve her overall quality of life.
Section 5
Two months after the intensified management plan was implemented, the patient returned for another follow-up, during which the healthcare team conducted a thorough assessment to evaluate her response to the interventions. Her blood pressure had improved slightly, now reading at 135/85 mmHg, and her heart rate remained stable at 88 bpm. The patient reported a modest improvement in her sleep quality; the frequency of nightmares had reduced to once every two weeks, and she felt slightly less fatigued during the day. She noted that incorporating mindfulness techniques into her daily routine helped her manage stress more effectively, though she still experienced irritability during high-pressure situations.
New diagnostic results showed a decrease in fasting glucose levels to 118 mg/dL, indicating a positive response to metformin and lifestyle changes. Her LDL cholesterol had decreased to 145 mg/dL, and her triglycerides were down to 180 mg/dL. Despite these improvements, her weight remained unchanged, which was a concern for the healthcare team, highlighting the need for further adjustment in her diet and physical activity. The mental health team observed that while her anxiety symptoms were better managed, she continued to exhibit mood swings, warranting a closer evaluation of her psychiatric medications and potential adjustments.
The healthcare team acknowledged the positive trends but recognized the necessity for ongoing monitoring and support. They encouraged the patient to maintain her mindfulness practices and emphasized the importance of consistent dietary adherence and increased physical activity to achieve further weight management. With these interventions, the team was cautiously optimistic about her trajectory, yet they remained vigilant for any potential setbacks or the emergence of new complications, ensuring that the patient felt supported and empowered in her journey towards improved health.